Skip to main content
OpenTrials

Clinical trial condition

Urologic Diseases

Explore clinical trials studying Urologic Diseases. Study availability and eligibility vary by location and protocol.

13,603 public trials 2,148 recruiting studies
Refine in advanced search Browse all conditions

Urologic Diseases trial results

Active, Not Recruiting

Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the Bladder

NCT03317158

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +15 more
Locations
  • BCG Oncology Phoenix, Arizona, United States
  • Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
  • Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
View Trial Details
Active, Not Recruiting

Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab

NCT06237920

Conditions
Antineoplastics Toxicity, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
Locations
  • Rijnstate Arnhem, Gelderland, Netherlands
  • Radboud University Medical Center Nijmegen, Gelderland, Netherlands
  • NKI-AVL Amsterdam, North Holland, Netherlands
  • Amsterdam UMC (AUMC) Amsterdam, North Holland, Netherlands
View Trial Details
Active, Not Recruiting

Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN)

NCT05248646

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • University of Alabama at Birmingham - Site #336 Birmingham, Alabama, United States
  • Mayo Clinic Arizona - Site #363 Phoenix, Arizona, United States
  • University of Arkansas for Medical Sciences - Site #353 Little Rock, Arkansas, United States
  • Amicis Research Center - Site #341 Granada Hills, California, United States
View all 308 locations
View Trial Details
Active, Not Recruiting

Savolitinib vs. Sunitinib in MET-driven PRCC.

NCT03091192

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations
  • Research Site La Jolla, California, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site Chicago, Illinois, United States
  • Research Site Iowa City, Iowa, United States
View all 59 locations
View Trial Details
Active, Not Recruiting

F15 Recharge Free Axonics SNM System Clinical Study

NCT06186765

Conditions
Digestive System Diseases, Fecal Incontinence, Fecal Incontinence (FI), +17 more
Locations
  • Hartford Healthcare Waterford, Connecticut, United States
  • Florida Gulf Clinical Research Bradenton, Florida, United States
  • East Coast Institute of Research Jacksonville, Florida, United States
  • Florida Bladder Institute Naples, Florida, United States
View all 16 locations
View Trial Details

Related conditions